Structures by: Užarević K.
Total: 31
C28H24N4O4Pd2
C28H24N4O4Pd2
Chemical communications (Cambridge, England) (2016) 52, 88 12960-12963
a=13.94260(10)Å b=18.57930(10)Å c=18.8456(2)Å
α=90° β=146.18° γ=90°
C28H24N4O4Pd2
C28H24N4O4Pd2
Chemical communications (Cambridge, England) (2016) 52, 88 12960-12963
a=15.7028(3)Å b=12.1884(3)Å c=27.7307(9)Å
α=90° β=90° γ=90°
4-oxopimelic acid 4,4'-bipyridine
C7H10O5,C10H8N2
New Journal of Chemistry (2011) 35, 1 24
a=15.8717(3)Å b=9.4064(2)Å c=17.3535(4)Å
α=90.00° β=140.5120(10)° γ=90.00°
4-oxo-heptane-1,7-dioic acid 4,4'-bipyridine
C7H10O5,C10H8N2
New Journal of Chemistry (2011) 35, 1 24
a=7.583(3)Å b=8.752(2)Å c=24.527(6)Å
α=90.00° β=92.29(3)° γ=90.00°
Cis-dioxo(N-3-methoxysalicylidene-2-amino -3- hydroxypyridine)(propanol)molybdenum(VI)
C16H18MoN2O6
CrystEngComm (2011) 13, 13 4314
a=7.7894(4)Å b=10.0907(7)Å c=12.5937(5)Å
α=86.293(4)° β=81.553(4)° γ=69.096(5)°
Cis-dioxo(N-3-methoxysalicylidene-2-amino-3-hydroxypyridine) (4-methylpyridine)molybdenum(VI) acetonitrile solvate
C19H17MoN3O5,C2H3N
CrystEngComm (2011) 13, 13 4314
a=8.8879(3)Å b=14.5134(5)Å c=16.4716(6)Å
α=90.00° β=90.433(3)° γ=90.00°
(Imidazole)cis-dioxo(N-3-methoxysalicylidene-2-amino -3- hydroxypyridine)molybdenum(VI) acetonitrile solvate
C16H14MoN4O5,C2H3N
CrystEngComm (2011) 13, 13 4314
a=7.5668(3)Å b=19.3973(7)Å c=14.5305(6)Å
α=90.00° β=116.626(3)° γ=90.00°
(4,4'-bipyridine)bis(cis-dioxo(N-3-methoxysalicylidene -2- amino-3-hydroxypyridine))dimolybdenum(VI) dichlormethane solvate
C36H28Mo2N6O10,2(CH2Cl2)
CrystEngComm (2011) 13, 13 4314
a=12.3420(12)Å b=13.4804(9)Å c=17.3437(16)Å
α=90.00° β=131.638(6)° γ=90.00°
(Ethanol)cis-dioxo(N-3-methoxysalicylidene-2-amino -3- hydroxypyridine)molybdenum(VI)
C15H16MoN2O6
CrystEngComm (2011) 13, 13 4314
a=8.0992(16)Å b=11.4036(11)Å c=17.993(3)Å
α=90.00° β=99.474(16)° γ=90.00°
(Imidazole)cis-dioxo(N-3-methoxysalicylidene -2-amino-3- hydroxypyridine)molybdenum(VI)
C16H14MoN4O5
CrystEngComm (2011) 13, 13 4314
a=7.4565(4)Å b=17.8707(14)Å c=12.2079(9)Å
α=90.00° β=93.021(6)° γ=90.00°
(Methanol)cis-dioxo(N-3-methoxysalicylidene-2-amino-3 - hydroxypyridine)molybdenum(VI)
C14H14MoN2O6
CrystEngComm (2011) 13, 13 4314
a=8.1890(7)Å b=10.9898(9)Å c=17.930(2)Å
α=90.00° β=105.346(9)° γ=90.00°
(4,4'-bipyridine)bis(cis-dioxo(N-3-methoxysalicylidene -2- amino-3-hydroxypyridine))dimolybdenum(VI)
C36H28Mo2N6O10
CrystEngComm (2011) 13, 13 4314
a=11.7871(6)Å b=12.8269(7)Å c=13.8071(6)Å
α=108.490(5)° β=94.104(4)° γ=113.811(5)°
Benzoylacetonatochlorobis(morpholine)copper(II)
C18H27ClCuN2O4,H2O
CrystEngComm (2012) 14, 21 7493
a=6.8963(2)Å b=11.7384(3)Å c=13.5638(3)Å
α=82.211(2)° β=84.292(5)° γ=73.527(3)°
(1,3-diphenyl-1,3-propanedionato)aquabis(morpholine)copper(II) chloride - morpholinium chloride
C23H31CuN2O5,C4H10NO,2Cl
CrystEngComm (2012) 14, 21 7493
a=11.1998(10)Å b=17.0668(10)Å c=8.4726(6)Å
α=90° β=102.461(8)° γ=90°
(2,2,6,6-tetramethyl-3,5-heptanedionato)chloroobis(morpholine)copper(II) monohydrate
C19H37ClCuN2O4,H2O
CrystEngComm (2012) 14, 21 7493
a=12.0852(3)Å b=9.7689(2)Å c=20.8357(4)Å
α=90° β=91.745(2)° γ=90°
(1,3-diphenyl-1,3-propanedionato)chlorobis(morpholine)copper(II) - morpholinium chloride morpholine solvate hydrate
2(C23H29ClCuN2O4),6(C4H9NO),C4H10NO,Cl,2(H2O)
CrystEngComm (2012) 14, 21 7493
a=15.888(5)Å b=16.700(3)Å c=17.261(13)Å
α=90° β=113.85(6)° γ=90°
1,1,1-trifluoroacetylacetonatochlorobis(morpholine)copper(II) - morpholine solvate
C13H22ClCuF3N2O4,C4H9NO
CrystEngComm (2012) 14, 21 7493
a=10.2419(7)Å b=13.1084(11)Å c=16.9868(12)Å
α=90° β=90° γ=90°
Acetylacetonatochlorobis(morpholine)copper(II)
C13H25ClCuN2O4
CrystEngComm (2012) 14, 21 7493
a=18.7558(11)Å b=10.1597(4)Å c=18.8355(12)Å
α=90° β=104.734(6)° γ=90°
Benzoylacetonatonitratobis(morpholine)copper(II)
C18H27CuN3O7
CrystEngComm (2012) 14, 21 7493
a=13.5493(6)Å b=11.3606(4)Å c=13.7432(6)Å
α=90° β=92.171(4)° γ=90°
(2,2,6,6-tetramethyl-3,5-heptanedionato)thiocyanatobis(morpholine)copper(II)
C20H37CuN3O4S
CrystEngComm (2012) 14, 21 7493
a=10.458(2)Å b=37.201(6)Å c=7.053(2)Å
α=90° β=108.72(2)° γ=90°
(1,3-diphenyl-1,3-propanedionato)thiocyanatobis(morpholine)copper(II)
C24H29CuN3O4S
CrystEngComm (2012) 14, 21 7493
a=6.4957(2)Å b=23.0280(10)Å c=8.5679(3)Å
α=90° β=102.451(4)° γ=90°
C20H26N3O6,CNS
C20H26N3O6,CNS
CrystEngComm (2015) 17, 16 3153
a=33.554(7)Å b=13.996(3)Å c=18.645(4)Å
α=90.00° β=100.54(3)° γ=90.00°
2(C20H26N3O6),2(ClO3),3(CH4O)
2(C20H26N3O6),2(ClO3),3(CH4O)
CrystEngComm (2015) 17, 16 3153
a=15.9465(6)Å b=18.9851(4)Å c=17.1610(7)Å
α=90.00° β=111.552(4)° γ=90.00°
C20H26N3O6,CNS,CH4O
C20H26N3O6,CNS,CH4O
CrystEngComm (2015) 17, 16 3153
a=8.0072(5)Å b=11.8432(9)Å c=13.3307(9)Å
α=96.449(6)° β=106.074(6)° γ=97.869(6)°
C20H26N3O6,Br,CH2O0.5
C20H26N3O6,Br,CH2O0.5
CrystEngComm (2015) 17, 16 3153
a=7.9370(5)Å b=12.8240(10)Å c=13.4850(10)Å
α=79.800(6)° β=76.802(6)° γ=78.839(6)°
C8H12NiO10,2(H2O)
C8H12NiO10,2(H2O)
Chemistry of Materials (2019) 31, 15 5494
a=6.9497(5)Å b=8.6455(5)Å c=12.4065(9)Å
α=89.144(5)° β=87.701(6)° γ=67.707(6)°
tetra-aqua-(2,5-dihydroxyterephthalato)-cobalt dihydrate
C8H12CoO10,2(H2O)
Chemistry of Materials (2019) 31, 15 5494
a=6.93886(14)Å b=8.6940(2)Å c=12.4532(3)Å
α=88.911(2)° β=87.481(2)° γ=68.358(2)°
C7H6O2,C5H5NO
C7H6O2,C5H5NO
Journal of the American Chemical Society (2019) 141, 3 1212-1216
a=8.47380(19)Å b=14.00094(36)Å c=11.47243(31)Å
α=90° β=125.36507(84)° γ=90°
C20H26N3O6,Br
C20H26N3O6,Br
CrystEngComm (2015) 17, 16 3153
a=7.9370(5)Å b=12.8236(10)Å c=13.4836(10)Å
α=79.804(6)° β=76.806(6)° γ=78.841(6)°
C12H14Cl2N4Pd2
C12H14Cl2N4Pd2
Inorganic chemistry (2017) 56, 9 5342-5351
a=9.89523(28)Å b=17.49071(46)Å c=4.500020(95)Å
α=90° β=111.5035(18)° γ=90°
C12H16.07Cl1N5.10Pd2
C12H16.07Cl1N5.10Pd2
Inorganic chemistry (2017) 56, 9 5342-5351
a=4.63647(15)Å b=11.68659(49)Å c=17.78582(64)Å
α=89.6394(35)° β=76.1249(36)° γ=111.6612(34)°